Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | 47 | 128 | 47 |
| Receivables | 0 | 23 | 533 | 208 | 410 |
| Inventories | N/A | N/A | N/A | 11 | 1 |
| TOTAL | $13 | $23 | $588 | $362 | $459 |
| Non-Current Assets | |||||
| PPE Net | 0 | 3 | 112 | 25 | 33 |
| Intangibles | 125 | 0 | 671 | 16 | 160 |
| Other Non-Current Assets | 0 | 0 | 10 | 0 | 0 |
| TOTAL | $125 | $3 | $793 | $42 | $193 |
| Total Assets | $137 | $25 | $1,381 | $403 | $652 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 97 | 58 | 24 | N/A | 115 |
| Accounts payable and accrued liabilities | N/A | N/A | 1,130 | 943 | 829 |
| Other current liabilities | N/A | N/A | 285 | 326 | 66 |
| TOTAL | $1,278 | $1,054 | $1,496 | $1,314 | $1,098 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 0 | 56 | 44 | 88 |
| Other Non-Current Liabilities | 0 | 0 | 10 | 40 | 39 |
| TOTAL | $0 | $0 | $24 | $40 | $39 |
| Total Liabilities | $1,278 | $1,054 | $1,520 | $1,354 | $1,137 |
| Shareholders' Equity | |||||
| Retained earnings | -28,331 | -25,419 | -27,786 | -25,685 | -22,964 |
| Other shareholders' equity | 0 | 0 | 60 | 0 | 0 |
| TOTAL | $-1,140 | $-1,029 | $-139 | $-950 | $-485 |
| Total Liabilities And Equity | $137 | $25 | $1,381 | $403 | $652 |